OmniAb, Inc. (OABI)
NASDAQ·Healthcare·Biotechnology
$1.97
-0.25%
Mkt Cap $252.47M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+103.6%
Consensus $4.00 vs current $1.97
NASDAQ·Healthcare·Biotechnology
$1.97
-0.25%
Mkt Cap $252.47M
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
+103.6%
Consensus $4.00 vs current $1.97